These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15642810)

  • 21. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
    Ong-Tone L
    J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.
    Yoshida J; Kim A; Pratzer KA; Stark WJ
    J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clearance of intravitreal moxifloxacin.
    Iyer MN; He F; Wensel TG; Mieler WF; Benz MS; Holz ER
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):317-9. PubMed ID: 16384979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
    Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
    Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
    Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
    Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreal penetration of oral and topical moxifloxacin in humans.
    Fuller JJ; Lott MN; Henson NM; Bhatti AA; Singh H; McGwin G; Marcus DM
    Am J Ophthalmol; 2007 Feb; 143(2):338-40. PubMed ID: 17258525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
    Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
    J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phakic status affects vitreous penetration of topical moxifloxacin.
    Fuller JJ; McGwin G
    Arch Ophthalmol; 2006 May; 124(5):749; author reply 749. PubMed ID: 16682605
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.
    Stewart WC; Crean CS; Zink RC; Brubaker K; Haque RM; Hwang DG
    Am J Ophthalmol; 2010 Nov; 150(5):744-751.e2. PubMed ID: 20813346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model.
    Asena L; Akova YA; Goktaş MT; Bozkurt A; Yaşar U; Karabay G; Demiralay E
    Curr Eye Res; 2013 Apr; 38(4):472-9. PubMed ID: 23373761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
    Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP
    Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Kampougeris G; Antoniadou A
    Eye (Lond); 2007 Sep; 21(9):1242-3; author reply 1243. PubMed ID: 17618246
    [No Abstract]   [Full Text] [Related]  

  • 33. Aqueous and vitreous penetration of levofloxacin after oral administration.
    Fiscella RG; Nguyen TK; Cwik MJ; Phillpotts BA; Friedlander SM; Alter DC; Shapiro MJ; Blair NP; Gieser JP
    Ophthalmology; 1999 Dec; 106(12):2286-90. PubMed ID: 10599658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
    Solomon R; Donnenfeld ED; Perry HD; Snyder RW; Nedrud C; Stein J; Bloom A
    Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Harper T; Miller D; Flynn HW
    Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor.
    Katz HR; Masket S; Lane SS; Sall K; Orr SC; Faulkner RD; McCue BA; Dahlin DC
    Cornea; 2005 Nov; 24(8):955-8. PubMed ID: 16227840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Robertson SM; Curtis MA; Schlech BA; Rusinko A; Owen GR; Dembinska O; Liao J; Dahlin DC
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penetration of moxifloxacin into the human aqueous humour after oral administration.
    Kampougeris G; Antoniadou A; Kavouklis E; Chryssouli Z; Giamarellou H
    Br J Ophthalmol; 2005 May; 89(5):628-31. PubMed ID: 15834098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
    Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
    Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1.
    Gomes RL; Viana RG; Melo LA; Cruz AC; Suenaga EM; Kenyon KR; Campos M
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):98-102. PubMed ID: 28231036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.